A phase I trial of ADS-4101 for the treatment of partial onset epileptic seizures in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 22 May 2017
At a glance
- Drugs ADS 4101 (Primary) ; Lacosamide (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Pharmacokinetics
- 22 May 2017 Results published in an Adamas Pharmaceuticals media release.
- 22 May 2017 According to an Adamas Pharmaceuticals media release, positive data from the Phase 1a trial will be presented at the 14th Antiepileptic Drug and Device Trials Conference.
- 08 Jan 2017 According to an Adamas Pharmaceuticals media release, the company anticipates to present the trial results at an upcoming medical conference.